Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion type Assertion NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_head.
- NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion description "[A total of 143 genetic polymorphisms in 13 candidate genes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, ALDH1A1, ALDH3A1, GSTA1, GSTM1, GSTP1, GSTT1, ABCC2 and ABCC4), possibly involved in the activation, metabolism and transport of CPA, were genotyped using 184 cases who developed either > or =grade 3 leukopenia/neutropenia or > or =grade 2 gastrointestinal toxicity and 219 controls who did not show any ADRs throughout the treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_provenance.
- NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion evidence source_evidence_literature NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_provenance.
- NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion SIO_000772 19696793 NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_provenance.
- NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion wasDerivedFrom befree-20140225 NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_provenance.
- NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_assertion wasGeneratedBy ECO_0000203 NP849979.RA3fQO0usZ6lxBerxAgj0ZZRLgG77X5D1VAdGUkjb3dLI130_provenance.